|
EP2595663A4
(en)
|
2010-07-19 |
2014-03-05 |
Isis Pharmaceuticals Inc |
MODULATION OF DYSTROPHIA MYOTONICA PROTEIN KINASE (DMPK) EXPRESSION
|
|
CA2817256A1
(en)
|
2010-11-12 |
2012-05-18 |
The General Hospital Corporation |
Polycomb-associated non-coding rnas
|
|
US9920317B2
(en)
|
2010-11-12 |
2018-03-20 |
The General Hospital Corporation |
Polycomb-associated non-coding RNAs
|
|
US10837014B2
(en)
|
2012-05-16 |
2020-11-17 |
Translate Bio Ma, Inc. |
Compositions and methods for modulating SMN gene family expression
|
|
EA201492122A1
(ru)
|
2012-05-16 |
2015-10-30 |
Рана Терапьютикс, Инк. |
Композиции и способы для модулирования экспрессии utrn
|
|
AU2013262699A1
(en)
|
2012-05-16 |
2015-01-22 |
Rana Therapeutics, Inc. |
Compositions and methods for modulating ATP2A2 expression
|
|
SG11201407483YA
(en)
|
2012-05-16 |
2014-12-30 |
Rana Therapeutics Inc |
Compositions and methods for modulating smn gene family expression
|
|
BR112014028631A2
(pt)
|
2012-05-16 |
2017-10-17 |
Rana Therapeutics Inc |
composições e métodos para modulação da expressão da família de genes da hemoglobina
|
|
EA201492116A1
(ru)
|
2012-05-16 |
2015-05-29 |
Рана Терапьютикс, Инк. |
Композиции и способы для модулирования экспрессии mecp2
|
|
JP2016523103A
(ja)
*
|
2013-06-26 |
2016-08-08 |
エランコ・ユーエス・インコーポレイテッドＥｌａｎｃｏ ＵＳ Ｉｎｃ． |
イヌ糸状虫病の病因であるディロフィラリア・イミティス（Ｄｉｒｏｆｉｌａｒｉａ ｉｍｍｉｔｉｓ）において大環状ラクトン耐性を予測するためのマーカー
|
|
TW201536329A
(zh)
|
2013-08-09 |
2015-10-01 |
Isis Pharmaceuticals Inc |
用於調節失養性肌強直蛋白質激酶(dmpk)表現之化合物及方法
|
|
US11236338B2
(en)
*
|
2013-09-05 |
2022-02-01 |
Sarepta Therapeutics, Inc. |
Antisense-induced exon2 inclusion in acid alpha-glucosidase
|
|
WO2015051283A1
(en)
|
2013-10-04 |
2015-04-09 |
Rana Therapeutics, Inc. |
Compositions and methods for treating amyotrophic lateral sclerosis
|
|
US11162096B2
(en)
|
2013-10-14 |
2021-11-02 |
Ionis Pharmaceuticals, Inc |
Methods for modulating expression of C9ORF72 antisense transcript
|
|
US10006027B2
(en)
|
2014-03-19 |
2018-06-26 |
Ionis Pharmaceuticals, Inc. |
Methods for modulating Ataxin 2 expression
|
|
EP3119888B1
(en)
|
2014-03-19 |
2021-07-28 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating ataxin 2 expression
|
|
HUE050704T2
(hu)
|
2014-04-01 |
2020-12-28 |
Biogen Ma Inc |
Összetételek a SOD-1 expressziójának modulálására
|
|
WO2016061487A1
(en)
*
|
2014-10-17 |
2016-04-21 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting aminolevulinic acid synthase-1 (alas1) and uses thereof
|
|
WO2016070060A1
(en)
|
2014-10-30 |
2016-05-06 |
The General Hospital Corporation |
Methods for modulating atrx-dependent gene repression
|
|
US10793855B2
(en)
*
|
2015-01-06 |
2020-10-06 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating expression of C9ORF72 antisense transcript
|
|
AU2016222546B2
(en)
|
2015-02-26 |
2020-01-23 |
Ionis Pharmaceuticals, Inc. |
Allele specific modulators of P23H rhodopsin
|
|
GB201504124D0
(en)
|
2015-03-11 |
2015-04-22 |
Proqr Therapeutics B V |
Oligonucleotides
|
|
WO2016149455A2
(en)
|
2015-03-17 |
2016-09-22 |
The General Hospital Corporation |
The rna interactome of polycomb repressive complex 1 (prc1)
|
|
US10407678B2
(en)
|
2015-04-16 |
2019-09-10 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating expression of C9ORF72 antisense transcript
|
|
US10801024B2
(en)
*
|
2015-05-20 |
2020-10-13 |
Indiana University Research And Technology Corporation |
Inhibition of lncRNA HOTAIR and related materials and methods
|
|
EP3124619B1
(en)
*
|
2015-07-31 |
2019-03-06 |
Menicon Co., Ltd |
Reagents, method and kit for across and within dog breed glaucoma diagnosis
|
|
JP2018538287A
(ja)
*
|
2015-12-14 |
2018-12-27 |
コールド スプリング ハーバー ラボラトリー |
多発性嚢胞腎の処置のためのアンチセンスオリゴマー
|
|
AU2016381174A1
(en)
|
2015-12-31 |
2018-05-31 |
Ionis Pharmaceuticals, Inc. |
Methods for reducing Ataxin-2 expression
|
|
AU2017213404A1
(en)
|
2016-01-29 |
2018-09-20 |
Kyowa Kirin Co., Ltd. |
Nucleic acid conjugate
|
|
WO2017134252A1
(en)
*
|
2016-02-05 |
2017-08-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antisense oligonucleotides effective to reduce the expression of menin in cancer cells of a subject
|
|
WO2017184529A1
(en)
|
2016-04-18 |
2017-10-26 |
Sarepta Therapeutics, Inc. |
Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene
|
|
JP2019514372A
(ja)
*
|
2016-04-20 |
2019-06-06 |
ジェービーエス サイエンス インコーポレイテッド |
Ｃｔｎｎｂ１およびｈｔｅｒｔにおける突然変異を検出するためのキットおよび方法、ならびにｈｃｃ検出および疾患管理におけるそれらの使用
|
|
AU2017286811A1
(en)
|
2016-06-17 |
2018-11-22 |
Ionis Pharmaceuticals, Inc. |
Modulation of gys1 expression
|
|
TWI746590B
(zh)
|
2016-06-30 |
2021-11-21 |
日商協和麒麟股份有限公司 |
核酸複合體
|
|
MX2018015722A
(es)
|
2016-07-01 |
2019-05-27 |
Hoffmann La Roche |
Oligonucleotidos antisentido para modular expresion del requisito de alta temperatura a 1 (htra1).
|
|
EP3481432A4
(en)
*
|
2016-07-05 |
2020-05-06 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Diagnosing col6-related disorders and methods for treating same
|
|
JOP20190104A1
(ar)
|
2016-11-10 |
2019-05-07 |
Ionis Pharmaceuticals Inc |
مركبات وطرق لتقليل التعبير عن atxn3
|
|
US11118182B2
(en)
|
2016-11-17 |
2021-09-14 |
Ramot At Tel-Aviv University Ltd. |
Modulators of human KAI1 metastasis suppressor gene, methods and uses thereof
|
|
CA3043768A1
(en)
|
2016-11-29 |
2018-06-07 |
PureTech Health LLC |
Exosomes for delivery of therapeutic agents
|
|
US11352625B2
(en)
|
2017-01-12 |
2022-06-07 |
Duke University |
Compositions and methods for disrupting the molecular mechanisms associated with mitochondrial dysfunction and neurodegenerative disease
|
|
JP7141621B2
(ja)
*
|
2017-03-31 |
2022-09-26 |
学校法人 愛知医科大学 |
コンドロイチン硫酸生合成を阻害するアンチセンス核酸
|
|
GB201706009D0
(en)
*
|
2017-04-13 |
2017-05-31 |
Proqr Therapeutics Ii Bv |
Antisense oligonucleotides for the treatment of stargardt disease
|
|
US20190055564A1
(en)
*
|
2017-06-01 |
2019-02-21 |
F. Hoffmann-La Roche Ag |
Antisense oligonucleotides for modulating htra1 expression
|
|
US20200208152A1
(en)
|
2017-09-08 |
2020-07-02 |
Mina Therapeutics Limited |
Stabilized sarna compositions and methods of use
|
|
WO2019048632A1
(en)
|
2017-09-08 |
2019-03-14 |
Mina Therapeutics Limited |
STABILIZED COMPOSITIONS OF SMALL ACTIVATORY RNA (PARNA) OF HNF4A AND METHODS OF USE
|
|
WO2019094315A1
(en)
*
|
2017-11-08 |
2019-05-16 |
Aptamer Diagnostic, Inc. |
D-dimer-specific aptamers and methods of use in diagnostics, therapeutic and theranostic purposes
|
|
TWI809004B
(zh)
|
2017-11-09 |
2023-07-21 |
美商Ionis製藥公司 |
用於降低snca表現之化合物及方法
|
|
KR102723989B1
(ko)
*
|
2017-12-01 |
2024-11-01 |
더 텍사스 에이 & 엠 유니버시티 시스템 |
엔젤만 증후군 안티센스 치료
|
|
BR112020016170A2
(pt)
*
|
2018-02-09 |
2020-12-15 |
Genentech, Inc. |
Oligonucleotídeos terapêutico e antissenso, conjugado, sal farmaceuticamente aceitável, composição farmacêutica, método in vitro ou in vivo para modular a expressão de tmem106b, método para tratar ou prevenir uma doença, uso do oligonucleotídeo e uso ou método
|
|
MX2020008581A
(es)
*
|
2018-02-21 |
2020-09-21 |
Bristol Myers Squibb Co |
Oligonucleotidos antisentido de la proteina cinasa del tipo ii delta dependiente del calcio/calmodulina (camk2d) y sus usos.
|
|
TWI840345B
(zh)
|
2018-03-02 |
2024-05-01 |
美商Ionis製藥公司 |
Irf4表現之調節劑
|
|
US11732260B2
(en)
|
2018-03-02 |
2023-08-22 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for the modulation of amyloid-β precursor protein
|
|
SG11202008660TA
(en)
|
2018-04-11 |
2020-10-29 |
Ionis Pharmaceuticals Inc |
Modulators of ezh2 expression
|
|
EP4663758A3
(en)
|
2018-05-09 |
2026-04-29 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for reducing atxn3 expression
|
|
TWI851574B
(zh)
|
2018-05-14 |
2024-08-11 |
美商阿尼拉製藥公司 |
血管收縮素原（ＡＧＴ）ｉＲＮＡ組成物及其使用方法
|
|
WO2020007700A1
(en)
*
|
2018-07-02 |
2020-01-09 |
Roche Innovation Center Copenhagen A/S |
Antisense oligonucleotides targeting spi1
|
|
WO2020007772A1
(en)
*
|
2018-07-02 |
2020-01-09 |
Roche Innovation Center Copenhagen A/S |
Antisense oligonucleotides targeting gbp-1
|
|
WO2020011653A1
(en)
*
|
2018-07-09 |
2020-01-16 |
Roche Innovation Center Copenhagen A/S |
Antisense oligonucleotides targeting kynu
|
|
WO2020015959A1
(en)
*
|
2018-07-19 |
2020-01-23 |
Stichting Katholieke Universiteit |
Antisense oligonucleotides rescue aberrant splicing of abca4.
|
|
AR115847A1
(es)
|
2018-07-25 |
2021-03-03 |
Ionis Pharmaceuticals Inc |
Compuestos y métodos para reducir la expresión de la atxn2
|
|
JP7529286B2
(ja)
*
|
2018-10-26 |
2024-08-06 |
フリーイェ・ユニヴェルシテイト・ブリュッセル |
肝特異的核酸調節エレメント並びにその方法及び使用
|
|
TW202028222A
(zh)
|
2018-11-14 |
2020-08-01 |
美商Ionis製藥公司 |
Foxp3表現之調節劑
|
|
BR112021013369A2
(pt)
|
2019-01-31 |
2021-09-21 |
Ionis Pharmaceuticals, Inc. |
Moduladores de expressão de yap1
|
|
CN113811311A
(zh)
*
|
2019-03-15 |
2021-12-17 |
马萨诸塞大学 |
用于组织特异性apoe调节的寡核苷酸
|
|
PT3947684T
(pt)
|
2019-03-29 |
2025-05-19 |
Ionis Pharmaceuticals Inc |
Compostos e métodos para modular ube3a‑ats
|
|
US11739324B2
(en)
|
2019-06-25 |
2023-08-29 |
Stichting Katholieke Universiteit |
Antisense oligonucleotides rescue aberrant splicing of ABCA4
|
|
US20220281911A1
(en)
|
2019-08-19 |
2022-09-08 |
Mina Therapeutics Limited |
Oligonucleotide conjugate compositions and methods of use
|
|
CN115279902A
(zh)
*
|
2019-08-30 |
2022-11-01 |
贝勒医学院 |
用于调控基因表达的系统
|
|
EP3822370A1
(en)
*
|
2019-11-15 |
2021-05-19 |
Curiosity Diagnostics Sp. z o.o. |
Method of determining the presence of a hyper-virulent clostridioides difficile strain of the b1/nap1/027 group in a sample
|
|
WO2021126997A1
(en)
*
|
2019-12-18 |
2021-06-24 |
Petdx, Inc. |
Methods and compositions for cancer detection, characterization or management in companion animals
|
|
KR20220133925A
(ko)
*
|
2020-01-31 |
2022-10-05 |
가부시키가이샤산와카가쿠켄큐쇼 |
Atn1의 안티센스 올리고뉴클레오티드
|
|
CN115812102B
(zh)
|
2020-02-12 |
2025-07-04 |
广州安天圣施医药有限公司 |
反义寡核苷酸及其在治疗耳聋-甲状腺肿综合征中的应用
|
|
EP4116419A1
(en)
*
|
2020-03-04 |
2023-01-11 |
Nissan Chemical Corporation |
Antisense oligonucleotide of calm2
|
|
AU2021265838A1
(en)
*
|
2020-04-29 |
2022-10-20 |
Saliogen Therapeutics, Inc. |
Compositions and methods for treatment of inherited macular degeneration
|
|
EP4172338A4
(en)
|
2020-06-29 |
2025-06-11 |
Ionis Pharmaceuticals, Inc. |
COMPOUNDS AND METHODS FOR MODULATING PLP1
|
|
KR20230095056A
(ko)
*
|
2020-07-22 |
2023-06-28 |
더 플로레이 인스티튜트 오브 뉴로사이언스 앤드 멘탈 헬스 |
Scn2a에서 기능-상실 돌연변이와 연관된 장애를 치료하기 위한 조성물 및 방법
|
|
CA3189922A1
(en)
|
2020-07-28 |
2022-02-03 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for reducing app expression
|
|
WO2022032017A2
(en)
*
|
2020-08-07 |
2022-02-10 |
The General Hospital Corporation |
Human xist antisense oligonucleotides for x reactivation therapy
|
|
EP4015040A1
(en)
*
|
2020-12-16 |
2022-06-22 |
Fundación para la Formación e Investigación Sanitarias de la Región de Murcia |
Method for treating blood diseases
|
|
WO2022133278A2
(en)
|
2020-12-18 |
2022-06-23 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulating factor xii
|
|
WO2022232687A1
(en)
*
|
2021-04-30 |
2022-11-03 |
Greenlight Biosciences, Inc. |
Messenger rna therapeutics and compositions
|
|
AU2022293556A1
(en)
|
2021-06-18 |
2024-01-18 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for reducing ifnar1 expression
|
|
WO2023004049A1
(en)
*
|
2021-07-21 |
2023-01-26 |
AcuraStem, Inc. |
Unc13a antisense oligonucleotides
|
|
WO2023034870A2
(en)
|
2021-09-01 |
2023-03-09 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for reducing dmpk expression
|
|
WO2023111337A1
(en)
*
|
2021-12-17 |
2023-06-22 |
F. Hoffmann-La Roche Ag |
Antisense oligonucleotide
|
|
WO2023139360A1
(en)
*
|
2022-01-19 |
2023-07-27 |
Autolus Limited |
Nucleic acid construct
|
|
WO2024064608A2
(en)
*
|
2022-09-20 |
2024-03-28 |
Intergalactic Therapeutics, Inc. |
Best1 vectors and uses thereof
|
|
GB202312098D0
(en)
*
|
2023-08-08 |
2023-09-20 |
Ucl Business Ltd |
Therapeutic molecules
|
|
AU2024339330A1
(en)
*
|
2023-09-13 |
2026-04-02 |
Haya Therapeutics Sa |
Compositions and methods for modulating wisp2 super-enhancer-associated rna
|
|
WO2025072672A2
(en)
*
|
2023-09-27 |
2025-04-03 |
Judo Bio, Inc. |
Slc6a19-targeting modulatory nucleic acid agents
|
|
GB202401412D0
(en)
*
|
2024-02-02 |
2024-03-20 |
Harness Therapeutics Ltd |
Functional nucleic acid
|
|
WO2026033502A1
(en)
*
|
2024-08-09 |
2026-02-12 |
Associação Biopolis |
Kit, method, and uses thereof
|
|
WO2026074434A1
(en)
*
|
2024-10-01 |
2026-04-09 |
Fondazione Istituto Italiano Di Tecnologia |
Rad51/brca2 complex aptamers and uses thereof
|